跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Amsutas - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Amsutas
Approved
STANDARD
Amsutas
Yeluri Formulation Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
bf22ebb629f070e4
Company
Yeluri Formulation Private Limited
Type
Standard
Approval Details
Approval Id
bf22ebb629f070e4
Drug Approval Philippines Name
Amsutas
Product Name
Amsutas
Registration Number
DRP-5007
Brand Name
Amsutas
Generic Name
Ampicillin (As Sodium) + Sulbactam (As Sodium)
Dosage Form
Powder for Injection (IM/IV)
Dosage Strength
500 mg/250 mg
Manufacturer
Yeluri Formulation Private Limited
Importer
Suhitas Pharmaceuticals, Inc.
Distributor
Suhitas Pharmaceuticals, Inc.
Issuance Date
29 May 2023
Expiry Date
11 December 2028
Pharmacologic Category
Antibacterial (Combination of penicillins including beta-lactamase inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
bf22ebb629f070e4
Type
Standard
Back to Philippines FDA Approvals